These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31369200)

  • 1. Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
    Lemmer A; VanWagner L; Gasanova Z; Helmke S; Everson GT; Ganger D
    Congenit Heart Dis; 2019 Nov; 14(6):978-986. PubMed ID: 31369200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology.
    Burton JR; Helmke S; Lauriski S; Kittelson J; Everson GT
    Transl Res; 2021 Jul; 233():5-15. PubMed ID: 33400995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child-Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine.
    Kanodia J; Giovinazzo H; Yates W; Bourdet DL; McRae MP; Helmke SM; Everson GT
    Clin Pharmacol Ther; 2024 Jul; 116(1):186-193. PubMed ID: 38654484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associated Factors of Liver Disease After Fontan Operation in Relation to Ultrasound Liver Elastography.
    Sethasathien S; Silvilairat S; Sittiwangkul R; Makonkawkeyoon K; Pongprot Y
    Pediatr Cardiol; 2020 Dec; 41(8):1639-1644. PubMed ID: 32740670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fontan-Associated Liver Disease: Evidence for Early Surveillance of Liver Health in Pediatric Fontan Patients.
    Rathgeber SL; Harris KC
    Can J Cardiol; 2019 Feb; 35(2):217-220. PubMed ID: 30760429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence.
    Hansen JH; Khodami JK; Moritz JD; Rinne K; Voges I; Scheewe J; Kramer HH; Uebing A
    Semin Thorac Cardiovasc Surg; 2022; 34(2):642-650. PubMed ID: 33979666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Fontan-associated liver disease.
    Dillman JR; Trout AT; Alsaied T; Gupta A; Lubert AM
    Pediatr Radiol; 2020 Oct; 50(11):1528-1541. PubMed ID: 32809067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
    Wu FM; Kogon B; Earing MG; Aboulhosn JA; Broberg CS; John AS; Harmon A; Sainani NI; Hill AJ; Odze RD; Johncilla ME; Ukomadu C; Gauvreau K; Valente AM; Landzberg MJ;
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):656-664. PubMed ID: 27955914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fontan-associated liver disease: Spectrum of US findings.
    Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
    Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary exercise testing in the evaluation of liver disease in adults who have had the Fontan operation.
    Agarwal A; Cunnington C; Sabanayagam A; Zier L; McCulloch CE; Harris IS; Foster E; Atkinson D; Bryan A; Jenkins P; Dua J; Parker MJ; Karunaratne D; Moore JA; Meadows J; Clarke B; Hoschtitzky JA; Mahadevan VS
    Arch Cardiovasc Dis; 2018 Apr; 111(4):276-284. PubMed ID: 29198937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group.
    Kutty SS; Zhang M; Danford DA; Hasan R; Duncan KF; Kugler JD; Quiros-Tejeira RE; Kutty S
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):678-684. PubMed ID: 26515874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac MRI-Derived Inferior Vena Cava Cross-Sectional Area Correlates with Measures of Fontan-Associated Liver Disease.
    Gunsaulus M; Wang L; Haack L; Christopher A; Feingold B; Squires J; Horslen S; Hoskoppal A; Rose-Felker K; West S; Trucco S; Squires J; Olivieri L; Kreutzer J; Goldstein B; Alsaied T
    Pediatr Cardiol; 2024 Apr; 45(4):909-920. PubMed ID: 36454265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC.
    Daniels CJ; Bradley EA; Landzberg MJ; Aboulhosn J; Beekman RH; Book W; Gurvitz M; John A; John B; Marelli A; Marino BS; Minich LL; Poterucha JJ; Rand EB; Veldtman GR
    J Am Coll Cardiol; 2017 Dec; 70(25):3173-3194. PubMed ID: 29268929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of liver abnormalities on mortality in Fontan patients: a systematic review and meta-analysis.
    Liu X; Han L; Zhou Z; Tu J; Ma J; Chen J
    BMC Cardiovasc Disord; 2024 Jul; 24(1):385. PubMed ID: 39054422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
    Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
    J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fontan-associated liver disease: Implications for heart transplantation.
    Greenway SC; Crossland DS; Hudson M; Martin SR; Myers RP; Prieur T; Hasan A; Kirk R
    J Heart Lung Transplant; 2016 Jan; 35(1):26-33. PubMed ID: 26586487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.